相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis A Systematic Review and Meta-Analysis
Tananchai Petnak et al.
CHEST (2021)
Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
Manon Belhassen et al.
RESPIRATORY RESEARCH (2021)
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Juergen Behr et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants
Victoria Allan et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort study
Mitra Corral et al.
BMC PULMONARY MEDICINE (2020)
Antifibrotic treatment improves clinical outcomes in patients with idiopathic pulmonary fibrosis: a propensity score matching analysis
Jieun Kang et al.
SCIENTIFIC REPORTS (2020)
Healthcare use and costs among Medicare enrollees on pirfenidone versus nintedanib for idiopathic pulmonary fibrosis
Mitra Corral et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
Paolo Cameli et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment - a German claims data analysis
Julia Waelscher et al.
RESPIRATORY RESEARCH (2020)
Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
Colin H. Holtze et al.
RESPIRATORY RESEARCH (2020)
Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis
Timothy M. Dempsey et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre
E. Bargagli et al.
PULMONOLOGY (2019)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis
Larissa Schwarzkopf et al.
RESPIRATORY RESEARCH (2018)
Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition
Reinhard Busse et al.
LANCET (2017)
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
Steven D. Nathan et al.
LANCET RESPIRATORY MEDICINE (2017)
Indices of Multiple Deprivation for the Analysis of regional Health Disparities in Germany Experiences from Epidemiology and Healthcare Research (vol 12, pg 1403, 2017)
Werner Maier
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2017)
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
Bram Rochwerg et al.
BMC MEDICINE (2016)
Drug Treatment of Idiopathic Pulmonary Fibrosis Systematic Review and Network Meta-Analysis
William J. Canestaro et al.
CHEST (2016)
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Luca Richeldi et al.
RESPIRATORY MEDICINE (2016)
Outcomes After Hospitalization in Idiopathic Pulmonary Fibrosis A Cohort Study
A. Whitney Brown et al.
CHEST (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials
Michael T. Durheim et al.
LANCET RESPIRATORY MEDICINE (2015)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11
Ganesh Raghu et al.
LANCET RESPIRATORY MEDICINE (2014)
Regional Deprivation and Mortality in Bavaria. Development of a Community-Based Index of Multiple Deprivation
W. Maier et al.
GESUNDHEITSWESEN (2012)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
分享论文
